Role of muscle relaxants in pediatric anesthesia

Current Opinion in Anaesthesiology

Volumn 20, Issue 3, 2007, Pages 227-231

  Meakin, George H ^a  

^a ROYAL MANCHESTER CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

Atracurium; Mivacurium; Neuromuscular block; Rocuronium; Succinylcholine; Sugammadex

Indexed keywords

ALFENTANIL; ANESTHETIC AGENT; ATRACURIUM; CISATRACURIUM; FENTANYL; HALOTHANE; ISOFLURANE; MIDAZOLAM; MIVACURIUM; MUSCLE RELAXANT AGENT; PANCURONIUM; PROPOFOL; REMIFENTANIL; ROCURONIUM; SEVOFLURANE; SUXAMETHONIUM; THIOPENTAL; VECURONIUM;

ANESTHESIA INDUCTION; ANESTHESIOLOGICAL TECHNIQUES; ARTIFICIAL VENTILATION; CARDIOVASCULAR EFFECT; CLINICAL PRACTICE; CLINICAL TRIAL; DRUG CHOICE; DRUG DOSE REDUCTION; DRUG UTILIZATION; ENDOTRACHEAL INTUBATION; HEART ARRHYTHMIA; HUMAN; HYPOTENSION; LARYNGEAL MASK; MUSCLE RELAXATION; PEDIATRIC ANESTHESIA; PRIORITY JOURNAL; REVIEW; SIDE EFFECT;

ADOLESCENT; ANESTHESIA; CHILD; CHILD, PRESCHOOL; HUMANS; INTRAOPERATIVE PERIOD; INTUBATION, INTRATRACHEAL; LARYNGEAL MASKS; NEUROMUSCULAR DEPOLARIZING AGENTS; NEUROMUSCULAR NONDEPOLARIZING AGENTS;

EID: 34247877722     PISSN: 09527907     EISSN: None     Source Type: Journal    
DOI: 10.1097/ACO.0b013e328108f430     Document Type: Review

References (50)

1. Foldes FF. The final steps leading to the anesthetic use of muscle relaxants. In: Fukushima K, Ochiai R, editors. Muscle relaxants. Tokyo: Springer; 1995. pp. 8-12.
2. Mason DG, Bingham RM. The laryngeal mask airway in children. Anaesthesia 1990; 45:760-763.
3. McKeating K, Bali IM, Dundee JW. The effects of thiopentone and propofol on upper airway integrity. Anaesthesia 1988; 43:638-640.
4. Martlew RA, Meakin G, Wadsworth R, et al. Dose of propofol for laryngeal mask airway insertion in children: effect of premedication with midozolam. Br J Anaesth 1996; 76:308-309.
5. Kihara S, Yaguchi Y, Inomata S, et al. Influence of nitrous oxide on minimum alveolar concentration of sevoflurane for laryngeal mask insertion in children. Anesthesiology 2003; 99:1055-1058.
6. Goudsouzian NG. Muscle relaxants in children. In: Cote CJ, Todres D, Goudsouzian NG, Ryan JF, editors. A practice of anesthesia for infants and children. Philadelphia: Saunders; 2001. pp. 196-215.
7. Rosenberg H, Gronert GA. Intractable cardiac arrest in children given succinylcholine. Anesthesiology 1992; 77:1054.
8. Robinson AL, Jerwood DC, Stokes MA. Routine suxamethonium in children. Anaesthesia 1996; 51:874-878.
9. Hatcher IS, Stack CG. Postal survey of the anaesthetic techniques used for paediatric tonsillectomy surgery. Paediatr Anaesth 1999; 9:311-315.
10. Rodney GE, Reichert CC, O'Regan DN, et al. Propofol or propofol/alfentanil compared to thiopentone/succinlycholine for intubation of healthy children. Can J Anaesth 1992; 39:A128.
11. Steyn MP, Quinn AM, Gillespie JA, et al. Tracheal intubation without neuromuscular block in children. Br J Anaesth 1994; 72:403-406.
12. Robinson DN, O'Brien K, Kumar R, et al. Tracheal intubation without neuromuscular blockade in children: a comparison of propofol combined either with alfentanil or remifentanil. Paediatr Anaesth 1998; 8:467-471.
13. Annila P, Vitanen H, Reinikainen P, et al. Induction characteristics of thiopentone/ suxamethonium, propofol/alfentanil or halothane alone in children aged 1-3 years. Eur J Anaesthesiol 1999; 16:359-366.
14. Batra YK, Al Qattan AR, Ali SS, et al. Assessment of tracheal intubation conditions in children using remifentanil and propofol without muscle relaxant. Paediatr Anaesth 2004; 14:452-456.
15. Crawford MW, Hayes J, Tan JM. Dose-response of remifentanil for tracheal intubation in infants. Anesth Analg 2005; 100:1599-1604.
16. Warner MA, Warner ME, Weber JG. Clinical significance of pulmonary aspiration during the peroperative period. Anesthesiology 1993; 78:56-62.
17. Holzman RS, Van der Velde ME, Kaus SJ, et al. Sevoflurane depresses myocardial contractility less than halothane during induction of anesthesia in children. Anesthesiology 1996; 85:1260-1267.
18. Johannesson GP, Floren M, Lindahl SG. Sevoflurane for ENT-surgery in children. A comparison with halothane. Acta Anaesthesiol Scand 1995; 39:546-550.
19. Inomata S, Watanabe S, Taguchi M, et al. End tidal sevoflurane concentration for tracheal intubation and minimum alveolar concentration in pediatric patients. Anesthesiology 1994; 80:93-96.
20. Inomata S, Nishikawa T. Determination of end tidal sevoflurane concentration for tracheal intubation with the rapid method. Can J Anaesth 1996; 43:806-811.
21. Swan DH, Crawford MW, Pua HL, et al. Additive contribution of nitrous oxide to sevoflurane minimum alveolar concentration for tracheal intubation in children. Anesthesiology 1999; 91:667-671.
22. Katoh T, Nakajima Y, Moriwaki G, et al. Sevoflurane requirements for tracheal intubation with and without fentanyl. Br J Anaesth 1999; 82:561-565.
23. Cros AM, Lopez C, Kandel T, et al. Determination of sevoflurane alveolar concentration for tracheal intubation with remifentil, and no muscle relaxant. Anaesthesia 2000; 55:965-969.
24. Blair JM, Hill DA, Bali IM, et al. Tracheal intubation conditions after induction with sevoflurane 8% in children. Anaesthesia 2000; 55:774-778.
25. Lerman J, Sikich N, Kleinman S, et al. The pharmacology of sevoflurane in infants and children. Anesthesiology 1994; 80:814-824.
26. McCluskey A, Meakin G. Dose-response and minimum time to satisfactory intubation conditions after mivacurium in children. Anaesthesia 1996; 51:438-441.
27. Hopkinson JM, Meakin G, McCluskey A, et al. Dose-response relationship and effective time to satisfactory intubation conditions after rocuronium in children. Anaesthesia 1997; 52:428-432.
28. Eikermann M, Renzing-Kohler K, Peters J. Probability of acceptable intubation conditions with low dose rocuronium during light sevoflurane anaesthesia in children. Acta Anaesthesiol Scand 2001; 45:1036-1041.
29. Ved SA, Chen J, Reed M, et al. Intubation with low-dose atracurium in children. Anesth Analg 1989; 68:609-613.
30. Frediani M, Capanna M, Casini L, et al. The use of low doses of intermediate acting muscle relaxants in adenotonsillectomy. Minerva Anestesiol 1993; 59:109-114.
31. Donati F. Tracheal intubation: unconsciousness, analgesia and muscle relaxation. Can J Anaesth 2003; 50:99-103.
32. Gray TC, Halton J. A milestone in anaesthesia? (D-tubocurarine chloride). Proc R Soc Med 1946; 39:400-410.
33. Ledowski T, Paech MJ, Patel B, et al. Bronchial mucus transport velocity in patients receiving propofol and remifentanil versus sevoflurane and remifentanil anesthesia. Anesth Analg 2006; 102:1427-1430.
34. Baird WLM, Reid AM. The neuromuscular blocking properties of a new steroid compound, pancuronium bromide: a pilot study in man. Br J Anaesth 1967; 39:775-780.
35. Meakin GH, Shaw EA, Baker RD, et al. Comparison of atracurium-induced neuromuscular blockade in neonates, infants and children. Br J Anaesth 1988; 60:171-175.
36. 2-propofol-fentanyl anesthesia.
37. 2-halothane. Anesthetic background and age have significant effects on intubating conditions.
38. Hadimioglu N, Ertugrul F, Ertug Z, et al. The comparative effect of single dose mivacurium during sevoflurane or propofol anesthesia in children. Paediatr Anaesth 2005; 15:852-857.
39. Roberts KD, Leone TA, Edwards WH, et al. Premedication for nonemergent neonatal intubations: a randomized, controlled trial comparing atropine and fentanyl to atropine, fentanyl, and mivacurium. Pediatrics 2006; 118:1583-1591. Administration of atropine, fentanyl and mivacurium compared with atropine and fentanyl without a muscle relaxant in neonates decreases the time required for intubation, number of attempts needed and incidence of severe desaturation.
40. Meretoja OA. Is vecuronium a long-acting neuromuscular blocking agent in neonates and infants? Br J Anaesth 1989; 62:184-187.
41. Burmester M, Mok Q. Randomised controlled trial comparing cisatracurium and vecuronium infusions in a paediatric intensive care unit. Intensive Care Med 2005; 31:686-692.
42. Nava-Ocampo AA, Velázquez-Armenta Y, Moyao-García D, et al. Meta-analysis of the differences in the time to onset of action between rocuronium and vecuronium. Clin Exp Pharmacol Physiol 2006; 33:125-130. Meta-analysis of the results of 21 studies indicated that the time to maximum block following a bolus dose of rocuronium was 20-70 s faster than that of vecuronium.
43. Bowman WC, Rodger IW, Houston J, et al. Structure:action relationships among some desacetoxy analogues of pancuronium and vecuronium in the anesthetized cat. Anesthesiology 1988; 69:57-62.
44. 50) compared with nitrous oxide-fentanyl anesthesia.
45. -1 of rocuronium in infants during nitrous oxide-halothane anaesthesia. Paediatr Anaesth 1994; 4:173-177.
46. Shevchenko Y, Jocson JC, McRae VA, et al. The use of lidocaine for preventing the withdrawal associated with the injection of rocuronium in children and adolescents. Anesth Analg 1999; 88:746-748.
47. Kim JY, Kim JY, Kim YB, et al. Pretreatment with remifentanil to prevent withdrawal after rocuronium in children. Br J Anaesth 2007; 98:120-123. Pretreatment with remifentanil reduced the incidence of withdrawal after intravenous injection of rocuronium by 71%.
48. Fuchs-Buder T, Tassonyi E. Intubating conditions and time course of rocuronium-induced neuromuscular block in children. Br J Anaesth 1996; 77:335-338.
49. Gijsenbergh F, Ramael S, Houwing N, et al. First human exposure of Org 25969, a novel agent to reverse the action of rocuronium bromide. Anesthesiolgy 2005; 103:695-703.
50. Shields M, Giovannelli M, Mirakhur RK, et al. Org 25969 (sugammadex), a selective relaxant binding agent for antagonism of prolonged rocuronium-induced neuromuscular block. Br J Anaesth 2006; 96:36-43. When two twitches of the train-of-four were present, 2 mg/kg of sugammadex restored the train-of-four ratio to 0.9 within 2 min.